Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA In Brief

This article was originally published in The Tan Sheet

Executive Summary

NSA switch prospects: FDA is "working hard" on WellPoint's citizen petition to switch non-sedating antihistamines OTC, Office of the Chief Counsel General Attorney Seth Ray says during FDLI Annual Educational Conference in Washington, D.C. April 2. In response to a question about whether FDA is "actively considering" a forced switch of Aventis' Allegra and Pfizer's Zyrtec, Ray noted "I think that's a fair assumption." When asked about potential classes of Rx drugs FDA might look to switch OTC, CDER Deputy Director Steven Galson, MD, said "we really haven't identified any as [a] top priority that we're working on...there's nothing that we're about to launch and announce in this regard." FDA recently stated its intention to become more proactive in Rx-to-OTC switches (1"The Tan Sheet" Feb. 10, 2003, p. 3)...

You may also be interested in...



Supplement Labeling Guide Set For Release This Year – FDA Guidance Agenda

FDA has started preliminary work on a Food Registration Implementation guidance, which the agency said is scheduled to come out after the release of its final rule on facility registration

Supplement Labeling Guide Set For Release This Year – FDA Guidance Agenda

FDA has started preliminary work on a Food Registration Implementation guidance, which the agency said is scheduled to come out after the release of its final rule on facility registration

Supplement Labeling Guide Set For Release This Year – FDA Guidance Agenda

FDA has started preliminary work on a Food Registration Implementation guidance, which the agency said is scheduled to come out after the release of its final rule on facility registration

Related Content

Topics

UsernamePublicRestriction

Register

PS095314

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel